ESTIV Congress > Abstract Submission

Abstract Submission

THANK YOU FOR YOUR ABSTRACTS!

The abstract submission is now closed. You will be notified about the acceptance of your abstract by July 12, 2022

Late poster submissions will be open in August 1st, 2022.

SEE THE PRELIMINARY PROGRAMME HERE


Abstract Guidelines

  1. Before submitting an abstract, it is essential to create a user account on the website.
  2. Abstracts (300 words) should cover original work that may already have been published recently. 
  3. Abstract body should be organised into the sections: Background and Objectives, Material and Methods, Results, Discussion and Conclusion
  4. There is no abstract submission fee.
  5. The presenting author is required to ensure that all co-authors are aware of the contents of the abstract before submission.
  6. More than 1 abstract can be submitted by the same first author. However, only 1 abstract can be selected for oral presentation. Additionally accepted abstracts will, therefore, be selected only for poster presentation only. A presenting author can only present 1 poster during the congress.
  7. Submission of an abstract implies a formal commitment by the designated presenting author to register for the congress and to present the abstract. However, registration is not required at the time of submission.
  8. Abstracts may not be edited/updated after final submission.
  9. Late-breaking abstract submissions will only be eligible for a poster presentation.
  10. All abstracts will be evaluated by the ESTIV2022 Scientific Committee and may be rejected or selected for oral or poster presentation.
  11. All abstracts accepted for presentation will be published in the abstract book and on the congress website prior to the congress.
  12. Please note that the corresponding author will receive all correspondence about the abstract. For this reason, it is strongly recommended that the presenting author also acts as the corresponding author.
  13. Your abstract is not successfully submitted until you receive a confirmation e-mail after clicking the final submit button. If you do not receive a confirmation e-mail, please contact us.

Please follow carefully these instructions. Abstracts not prepared correctly will not be considered for presentation. 

Topics for abstract submission

  • Bio-engineering, stem cells and disease models
  • Models, biomarkers and assays for endocrine disruption and developmental toxicity
  • Models, biomarkers and assays for systemic and immune toxicity
  • Organ-on-chip models
  • Challenges in EU Cosmetic regulation
  • Computational toxicology – in silico modelling, read-across, artificial intelligence and machine learning
  • Local toxicity testing (safety and efficacy)
  • Toxicokinetics and in vitro – in vivo extrapolation
  • Animal product free NAMs
  • In vitro methods for safety testing of biopharmaceuticals/biotherapies/vaccines
  • NAMs in the Environmental toxicity / Green deal
  • Mixtures and biomonitoring
  • In vitro COVID-19 research/lung and cardiovascular models
  • In vitro methods for safety assessment of medical devices
  • GIVIMP, GCMP and GLP
  • Other

Instructions for presenters

Oral presentation
Instructions will be sent to participants shortly before start of ESTIV2022.

Posters
Instructions will be sent to participants shortly before start of ESTIV2022.
The poster size for all paper posters is A0 portrait format, 841 mm x 1189 mm. No other specific format for poster layout (structure / layout) is prescribed.